±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 7120  |  »Ø¸´: 29

³ÕÃÎäìÏæ

ľ³æ (ÖøÃûдÊÖ)


[½»Á÷] ÖµµÃ¾«¶ÁµÄһƪ¹úÄÚ·¢±íµÄNature Chemical Biology ÒÑÓÐ27È˲ÎÓë

¹úÄÚ²ÎÓ뵥λ£º¹ú¼ÒÉúÃü¿ÆÑ§Ñо¿Ëù¡¢Ìì½ò´óѧ
ÕâÆªÎÄÕÂÈ·Ö¤ÁËËÀÍöÊÜÌåDR5×÷Ϊ¿¹Ö×Áö°Ð±ê£¬²¢É¸Ñ¡³öµÚÒ»¸öС·Ö×ÓÏȵ¼»¯ºÏÎ¹±Ï×ºÜ´ó£¬Æª·ù½Ï¶Ì£¬¸²¸Çµ±´úÉúÎﻯѧ¸÷ÖÖ¼¼Êõ£¬·Ç³£ÖµµÃ¾«¶Á¡£ÎÄÕÂÄÚÈݼ°±³¾°´óÌåÈçÏ£º
ϸ°ûµòÍö£¨apoptosis£©ÓÐÈýÌõÐźÅͨ·£¬¼´£ºËÀÍöÊÜÌåÐźÅͨ·¡¢ÏßÁ£ÌåÐźÅͨ·¡¢ÄÚÖÊÍøÐźÅͨ·£¬ÆäÖеÚÒ»ÌõΪÍâÔ´ÐÔÐźÅͨ·£¨extrinsic pathway£©£¬ºóÁ½ÌõΪÄÚÔ´ÐÔÐźÅͨ·£¨intrinsic pathway£©¡£
ͼ1. ϸ°ûµòÍöÐźÅͨ·

ͼ2. ËÀÍöÊÜÌåÐźÅͨ·

ËÀÍöÊÜÌ壨death receptors£©ÊÇÒ»ÖÖ¿çĤµ°°×£¬ÓÐTNFÊÜÌå¡¢FasLÊÜÌå¡¢DRÈý´óÀ࣬Æä°ûÍâÇø£¨extracellular domain£©ÓëÏàÓ¦µÄÅäÌå½áºÏºó£¬¾ÛºÏÐγÉͬԴÈý¾ÛÌå¡£Èý¾ÛÌ帴ºÏÎïͨ¹ýÆä°ûÄÚµÄËÀÍö½á¹¹Óò£¨death domain£©£¬ÓëÏνӵ°°×£¨adaptor protein£©FADD½áºÏ¡£FADDÒ»ÖÖÁ¬½Óµ°°×£¬C-¶ËΪËÀÍö½á¹¹Óò£¬N-¶ËΪËÀÍöЧӦ½á¹¹Óò£¨death-effector domain£©£¬Äܹ»ÓëCaspase-8½áºÏ£¬ÐγÉËÀÍöÓÕµ¼ÐźŸ´ºÏÌ壨death-inducing signaling complex£¬DISC£©¡£
TNF£ºtumor necrosis factor£¬Ö×Áö»µËÀÒò×Ó
FasL£ºFas ligand£¬Fas¿¹Ô­ÅäÌå
TRAIL£ºtumor necrosis factor-related apoptosis-inducing ligand£¬Ö×Áö»µËÀÒò×ÓÏà¹ØµòÍöÓÕµ¼ÅäÌå
FADD£ºFas-associated death domain£¬FasÏà¹ØËÀÍö½á¹¹Óò
FasLÊÜÌå±»³ÆÎªFas»òCD95£»TNFÊÜÌåÓÐÁ½ÖÖÑÇÐͼ´TNFR-1ºÍTNFR-2£¬ÆäÖÐTNFR-1ÓÐFADD¶øTNFR-2ûÓУ»DRÓÐÈýÖÖÑÇÐÍ£¬ÆäÖÐDR-3±»³ÆÎªApo-3£¬DR-4¼´TRAILR-1£¬DR-5¼´TRAILR-2¡£
CaspaseÊÇÒ»×é´æÔÚÓÚϸ°ûÖÊÖеĵ°°×ø£¬È«³ÆÎªº¬°ëë×°±ËáµÄÌ춬°±Ëáµ°°×Ë®½âø£¬Äܹ»ÌØÒìÐÔµÄÇиî°Ðµ°°×Ì춬°±Ëá²Ð»ùÉϵÄëļü¡£»î»¯µÄCaspase-8¿É¼¤»îÏÂÓεÄCaspase-3¡¢Caspase-6¡¢Caspase-7£¬¼¤»îϸ°ûµòÍöÏÂÓÎÐźÅͨ·¡£
Caspase-3¡¢Caspase-6¡¢Caspase-7µÄ»îÐÔÊܵ½IAP¼Ò×åµ°°×£¨ÈçXIAP¡¢cIAP1¡¢cIAP2£©µÄÒÖÖÆ£¬¶ø½â³ýIAPµÄÒÖÖÆÒÀÀµÏßÁ£ÌåµÄµòÍöÐźÅSmac/Diablo¡£SmacÄÜÓëIAPµÄBir-½á¹¹Óò½áºÏ£¬½â³ýIAP¶ÔCaspaseµÄÒÖÖÆ×÷Ó㬲¢ÓÕµ¼IAPµÄ½µ½â¡£
IAP£ºinhibitor of apoptosis proteinϸ°ûµòÍöÒÖÖÆµ°°×
SmacÓëIAP½áºÏµÄ¹Ø¼üÊÇN-¶ËµÄ±û°±Ëá¡¢çÓ°±Ëá¡¢¸¬°±Ëá¡¢ÒìÁÁ°±ËáËĸö°±»ùËá²Ð»ù£¬¿ÆÑ§¼ÒÒѾ­ÓÃëÄÄ£Äâ·½·¨£¨peptido-mimetic approach£©¿ª·¢³öС·Ö×Ó»¯ºÏÎ²úÉúÓëSmacÏàËÆµÄ»îÐÔ£¬ÓÕµ¼Ï¸°ûµòÍö¡£
Ñо¿ÈËԱɸѡÁË200,000¸ö»¯ºÏÎѰÕÒÄÜÓëSmacÄ£ÄâÎSmac mimetic, SM£©²úÉúЭͬ×÷ÓõϝºÏÎsynergist£©£¬É¸Ñ¡ÓÃϸ°ûΪT98Gϸ°ûÖ꣨È˽ºÖÊÁöϸ°ûÖ꣩¡£³õɸ·¢ÏÖ2,068»¯ºÏÎï£¬Ëæºó·¢ÏÖ24¸ö»¯ºÏÎïÄÜÔÚ15¦Ì¦¬Å¨¶ÈÏÔÖøÔöÇ¿SMÒÖÖÆÖ×ÁöµÄ»îÐÔ¡£É¾È¥Ï¸°û¶¾ÐÔ´óµÄ£¬Ö»Ê£ÏÂ4¸ö»¯ºÏÎ×ödose-response·ÖÎö£¬×îÖÕɸѡ³ö»¯ºÏÎïA2C2×÷½øÒ»²½Ñо¿¡£
ͼ3. ·¢ÏÖËÀÍöÊÜÌ弤¶¯¼Á

°´ÕÕA2C2µÄ½á¹¹£¬Ñо¿ÈËÔ±ºÏ³ÉÁËÕâÒ»»¯ºÏÎµ«Ææ¹ÖµÄÊǺϳɳöµÄ»¯ºÏÎ¼ÇΪA1£©ÍêȫûÓлîÐÔ£¬Òâζ×ÅA1ÓëA2C2²»ÊÇͬһÖÖÎïÖÊ£¬ÎÊÌâ³öÔÚÄÄÄØ£¿¾­¹ý´óÁ¿NMRºÍLC/MS·ÖÎö£¬È·Ö¤A2C2ʵΪÈýÖÖÖØÅŲúÎA1¡¢C2¡¢A2£©µÄ»ìºÏÎÓлîÐÔµÄÊÇA2+C2¡£ËæºóÊÇһϵÁнṹÐÞÊκϳɣ¬·¢ÏÖ»¯ºÏÎïbioymifiÓкܺõĻîÐÔ£¬ÒÖÖÆÖ×Áöϸ°û²»ÐèÒªSMµÄЭͬ×÷Ó㬲¢ÇÒ¶Ô¶à¸öÖ×Áöϸ°ûÖêÓÐÒÖÖÆ»îÐÔ£¬ÏÂÒ»²½¾ÍÊÇѰÕÒbioymifiµÄ×÷ÓðеãÁË¡£
        ÔÚ¸øÓèbioymifiºÍSMµÄͬʱ£¬¸øÓèpan-caspaseÒÖÖÆ¼ÁZ-VAD£¨Z-VADÄÜÒÖÖÆCaspaseµÄ»îÐÔ£¬×è¶Ïϸ°ûµòÍöÐźÅͨ·£©£¬·¢ÏÖ²»ÄÜÓÐЧÒÖÖÆÖ×Áö£¬Õâ˵Ã÷bioymifi¼¤»îÁËϸ°ûµòÍöÐźÅͨ·¡£ÎªÁ˽øÒ»²½È·¶¨bioymifi×÷ÓÃÓÚÄÄÒ»ÌõÐźÅͨ·£¬Ñо¿ÈËԱʹÓÃsiRNA·Ö±ð³ÁĬT98Gϸ°ûµÄCaspase-8ºÍCaspase-9±àÂëÇø£¬×îÖÕÈ·¶¨bioymifiºÍSMÒÖÖÆµÄÊÇCaspase-8ËùÔÚÐźÅͨ·¼´ÍâÔ´µòÍöÐźÅͨ·¡£
        ÓëCaspase-8ÓйصÄËÀÍöÊÜÌåÓÐFas¡¢TNFR-1¡¢DR3¡¢DR4¡¢DR5µÈÀàÐÍ£¨×¢TNFR-2ÎÞFADD£¬²ÎÓëNF-¦ÊBÓÕµ¼Ï¸°ûµòÍö£¬²»¾­Caspase-8£©£¬bioymifiÓëÄÇÖÖËÀÍöÊÜÌåÓйØÄØ£¿Í¨¹ýRNAiɸѡ£¬³ÁĬDR5»ùÒò£¬Äܹ»Äæ×ªbioymifiÓÕµ¼µÄµòÍö£¬²¢ÇÒbioymifiÏÔʾ³öµÄ½á¹ûÓëTRAIL£¨DR5µÄԭʼÅäÌ壩һÖ¡£
        ËæºóµÄÃâÒß³Áµí£¨immunoprecipitate£©ºÍÃâÒßÓ¡¼£·ÖÎö£¨western blot analysis£©Ö¤Êµ£¬bioymifi»òTRAIL´¦ÀíºóµÄT98Gϸ°ûÖУ¬¾ù¼ì²âµ½FADD¡¢TRADD¡¢RIPK1µÈÓëDISCÏà¹ØµÄµ°°×£¬¶ø¶ÔÕÕϸ°û¼ì²â²»µ½¡£
        ÁíÒ»·½Ã棬¸øÓèTRAILµÄͬʱ¸øÓèTRAIL¿¹Ì壬TRAILʧȥÓÕµ¼Ï¸°ûµòÍöµÄÄÜÁ¦¡£¸øÓèTRAILµÄͬʱ¸øÓèbioymifi£¬ÓÕµ¼Ï¸°ûµòÍöÄÜÁ¦ÎÞÃ÷ÏÔ²îÒì¡£³ÁĬÓÃsiRNA³ÁĬTRAIL»ùÒò£¬²»Ó°ÏìbioymifiÓÕµ¼Ï¸°ûµòÍöµÄÄÜÁ¦¡£
        ΪÁ˽øÒ»²½È·Ö¤bioymifiµÄ×÷Óðе㣬Ñо¿ÈËÔ±½öº¬°ûÍâÇøµÄDR4ÓëDR5£¬·¢ÏÖbioymifiÓëDR5µÄÇ׺ÍÁ¦½ÏºÃ£¬KdÖµÔÚ1.2¦Ì¦¬£¬ÓëDR4ÎÞÇ׺ÍÁ¦¡£DSDµçÓ¾¡¢·Ö×ÓÅÅ×èÉ«Æ×µÈ¼ì²âµ½¸ß·Ö×ÓÁ¿µÄ¾ÛºÏÎ֤Ã÷bioymifiÄÜÓÕµ¼DR5µÄ¾ÛºÏ£¬Ï¸°û³ÉÏñÒ²¹Û²ìµ½ÁËÃ÷ÏÔµÄfoci  ½á¹¹£¬DR4ÎÞÕâЩÏÖÏó¡£
        ×ÛÉÏ£¬·¢ÏÖÁ˵ÚÒ»¸öÑ¡ÔñÐÔС·Ö×ÓDR5¼¤¶¯¼Á¡£
Reference: Small-molecule activation of the TRAIL receptor DR5 in human cancer cells. Nature Chemical Biology. doi:10.1038/nchembio.1153.

ÎÄÏ×ÏÂÔØ£º
»Ø¸´´ËÂ¥

» ±¾Ìû¸½¼þ×ÊÔ´Áбí

  • »¶Ó­¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
    ±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com
  • ¸½¼þ 1 : nchembio.1153.pdf
  • 2013-01-11 20:33:03, 801.94 K

» ÊÕ¼±¾ÌûµÄÌÔÌûר¼­ÍƼö

·Ö×ÓÉú»¯ÊµÑé¾­Ñé»ýÀÛ Ñо¿Éú×ÊÁÏ ¿¼Ñи´Ï° ѧÊõ±¨¸æ-»¯Ñ§
ÄÉÃ×ÉúÎïÀà Ö×ÁöÑо¿ Óлú useful

» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
»ØÌûÖ§³Ö ( ÏÔʾ֧³Ö¶È×î¸ßµÄǰ 50 Ãû )

½ú°ÔÏÉ

гæ (³õÈëÎÄ̳)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ËäÈ»²»ÊÇÏà¹Ø×¨ÒµÁìÓòµÄ¶«Î÷£¬µ«ÊÇÊǺö«Î÷£¬¸ÐлLZ~£¡
´ýÎÒ³¤·¢¼°Ñü£¬Äã¹À¼ÆÒѾ­²»ÐÐÁË~--£¡£¡£¡
3Â¥2013-01-12 16:09:50
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

luck_cc

½ð³æ (ÕýʽдÊÖ)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Ñо¿µÄÕâô͸³¹µÄºÃÎÄÕ£¬Ð»Ð»Â¥Ö÷·ÖÏí
ÈÏÕæÄ¿±ê£¬ÓÂÍùֱǰ
5Â¥2013-01-13 10:22:06
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

mayree

гæ (³õÈëÎÄ̳)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ÉÏÃæÄÇÁ½ÕÅͼÓÐÎÄÏ×Á´½ÓÂð
28Â¥2015-09-25 09:10:55
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
ÆÕͨ»ØÌû

diandong

½û³æ (ÖøÃûдÊÖ)

ËÍÏÊ»¨Ò»¶ä
±¾ÌûÄÚÈݱ»ÆÁ±Î

2Â¥2013-01-12 15:52:36
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
ËÍÏÊ»¨Ò»¶ä
лл·ÖÏí
4Â¥2013-01-13 09:01:50
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zxh049

гæ (³õÈëÎÄ̳)

лл¥Ö÷£¬ÐÁ¿àÁË

[ ·¢×ÔÊÖ»ú°æ http://muchong.com/3g ]
6Â¥2013-01-13 10:48:42
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ΰ×

ľ³æ (ÖøÃûдÊÖ)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
¹ØÒµÏà¹Ø£¬Â¥Ö÷Å£È˰¡£¬Çë¶àÖ¸½Ì¡£

[ ·¢×ÔÊÖ»ú°æ http://muchong.com/3g ]
Ììû½µ´óÈÎÓÚÎÒ£¬ÕÕÑù¿àÎÒÐÄÖÇ£¬ÀÍÎÒ½î¹Ç£¬¶öÎÒÌå·ô£¬¿Õ·¦ÎÒÉí£¬Ðи¥ÂÒÎÒËùΪ£¡
7Â¥2013-01-13 11:21:16
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

imhnwam

Òø³æ (СÓÐÃûÆø)

ºÃÑùµÄ
8Â¥2013-01-13 13:40:56
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

bebruce

½ð³æ (ÕýʽдÊÖ)

²»´í°¡
Ï£ÍûÔÚÕâÀïÎÒÃÇÄÜ»¥Ïà°ïÖú
9Â¥2013-01-13 22:23:25
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

jeffwh

½ð³æ (ÕýʽдÊÖ)

Ã÷Ìì¶Á£¬Ð»Ð»Â¥Ö÷

[ ·¢×ÔÊÖ»ú°æ http://muchong.com/3g ]
ÇÐʵ¿ÉÐÐ
10Â¥2013-01-14 00:50:41
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ³ÕÃÎäìÏæ µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Ò»Ö¾Ô¸211£¬»¯Ñ§Ñ§Ë¶£¬310·Ö£¬±¾¿ÆÖصãË«·Ç£¬Çóµ÷¼Á +4 ŬÁ¦·Ü¶·112 2026-04-07 4/200 2026-04-07 10:30 by unicornone
[¿¼ÑÐ] 284Çóµ÷¼Á +11 èó@@ 2026-04-06 11/550 2026-04-07 09:33 by lovelychen
[¿¼ÑÐ] Ò»Ö¾Ô¸¹þ¹¤´ó£¬³õÊÔ329£¬Çó»·¾³¿ÆÑ§Ó빤³Ìµ÷¼Á£¡ +6 ÓàδÐÁ 2026-04-06 6/300 2026-04-06 20:51 by lbsjt
[¿¼ÑÐ] 318Çóµ÷¼Á +12 ykyhsa 2026-04-05 14/700 2026-04-06 17:46 by fuyu_
[¿¼ÑÐ] ÇóÖú +3 ¿¨¿¨¶«88 2026-04-06 4/200 2026-04-06 15:28 by going home
[¿¼ÑÐ] 0857´óÀà»·¾³¹¤³ÌBÇøÇóµ÷¼Á +3 ¹¨ÓíÃú 2026-04-05 3/150 2026-04-06 10:22 by À¶ÔÆË¼Óê
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +5 asdasdassda 2026-04-05 5/250 2026-04-06 09:32 by dongzh2009
[¿¼ÑÐ] ¿¼Ñе÷¼Á +5 ÃÀÀöµÄyouth_ 2026-04-04 6/300 2026-04-06 06:57 by houyaoxu
[¿¼ÑÐ] 085600£¬320·ÖÇóµ÷¼Á +7 ´ó²öС×Ó 2026-04-01 8/400 2026-04-05 21:19 by ѧԱ8dgXkO
[¿¼ÑÐ] µ÷¼Á +5 ºÃºÃ¶ÁÊé¡£ 2026-04-01 5/250 2026-04-05 17:54 by liucky
[¿¼ÑÐ] 085602 ÕÒµ÷¼Á +4 ÄæÊ±Õë¿ìÀÖ 2026-04-02 4/200 2026-04-04 19:32 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 325Çóµ÷¼Á +4 ´º·ç²»½èÒâ 2026-04-04 4/200 2026-04-04 14:46 by ÏæÅ©´¢ÄܲÄÁÏ
[¿¼ÑÐ] һ־Ը˫·Ç085502£¬267·Ö£¬¹ýËļ¶Çóµ÷¼Á +3 ÔÙæҲҪ³Ô·¹°¡ 2026-04-03 3/150 2026-04-04 05:03 by gswylq
[¿¼ÑÐ] 265Çóµ÷¼Á +17 ÁÖÉîÎÂÀ½ 2026-04-01 20/1000 2026-04-04 01:09 by userper
[¿¼ÑÐ] »úеר˶297 +3 Afksy 2026-04-03 3/150 2026-04-03 14:24 by 1753564080
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©½»Í¨´óѧ²ÄÁϹ¤³Ì×Ü·Ö358 +4 cs0106 2026-04-03 4/200 2026-04-03 13:41 by °ÙÁéͯ888
[¿¼ÑÐ] 303Çóµ÷¼Á +3 һɫÇåÓð 2026-04-02 4/200 2026-04-03 10:22 by À¶ÔÆË¼Óê
[¿¼²©] É격ÇóÖú +3 Reee1Llll 2026-04-01 3/150 2026-04-02 22:29 by ÕâÊÇÒ»¸öÎÞÁĵÄê
[¿¼ÑÐ] 366Çóµ÷¼ÁÒ»Ö¾Ô¸¶«±±´óѧ +8 ÔËÆøÀ´µÃÈôÓÐËÆÎ 2026-04-02 8/400 2026-04-02 21:39 by dongzh2009
[¿¼ÑÐ] 348»·¾³¹¤³Ìµ÷¼Á +3 ÎâÑå׿24k 2026-04-01 3/150 2026-04-02 09:14 by nanaliuyun
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û